Form 4: Immunovant Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Julia G. Butchko, Chief Development Officer of Immunovant, Inc., sold 1,527 shares of common stock to cover tax withholding obligations related to the vesting of restricted stock units.
Summary
- On July 9, 2024, Julia G. Butchko, Chief Development Officer of Immunovant, Inc., sold 1,527 shares of Immunovant's common stock.
- The sale was executed to cover tax withholding obligations associated with the vesting of 3,406 restricted stock units (RSUs) on July 1, 2024.
- The shares were sold at a weighted average price of $28.06, with individual transactions ranging from $27.48 to $28.42 per share.
- Following the transaction, Butchko directly owns 446,853 shares of Immunovant common stock.
- The sale was mandated by Immunovant's policy requiring tax obligations to be funded through a 'sell to cover' transaction.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the transaction is a routine sale to cover tax obligations and doesn't indicate a change in the executive's confidence in the company.
Industry Context
Form 4 filings are a routine part of the US stock market, providing transparency into the transactions of company insiders. This transaction is a standard 'sell to cover' arrangement, common for executives receiving equity compensation.
Key Dates
| Date | Description |
|---|---|
| 2021/03/19 | Date of grant of 54,500 restricted stock units (RSUs) to the holder. |
| 2021/03/23 | Date of Form 4 filing reporting the grant of 54,500 RSUs. |
| 2024/07/01 | Date 3,406 RSUs vested. |
| 2024/07/09 | Date of the stock sale transaction. |
| 2024/07/10 | Date of the signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.